Akums Drugs and Pharma shares list at 7% premium over issue price

August 6, 2024

Akums Drugs and Pharmaceuticals’ shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subscribed 63.5 times. The company will use the IPO proceeds for debt repayment, working capital, and acquisitions. Revenue grew 14% in FY24, while profits saw a decline.

More To Explore

All that glitters is not gold on the IPO street

Amid booming IPO market, caution is in the air for investors as majority of the companies that were listed in 2024 failed to retain their

December 26, 2024

Bollywood stars, Ashish Kacholia-backed Sri Lotus Developers files for Rs 792-cr IPO

Mumbai-based realty developer Sri Lotus Developers and Realty has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, the Securities and Exchange Board

December 26, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003